Farmacogenómica del Cáncer ; Pharmacogenomic of cancer
Gedelcan
Hospital Universitario de Guadalajara
Guadalajara, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (119)
2024
-
Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3
Histology and histopathology, Vol. 39, Núm. 1, pp. 35-40
-
Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients
Histology and histopathology, Vol. 39, Núm. 9, pp. 1133-1140
-
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
British Journal of Surgery, Vol. 111, Núm. 1
-
Exacerbated Activation of the NLRP3 Inflammasome in the Placentas from Women Who Developed Chronic Venous Disease during Pregnancy
International Journal of Molecular Sciences, Vol. 25, Núm. 10
-
Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice
Medicina (Lithuania), Vol. 60, Núm. 1
-
Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer
Current Issues in Molecular Biology, Vol. 46, Núm. 5, pp. 3839-3865
-
Ultrasound in the differential diagnosis of two painful nail lesions
Piel, Vol. 39, Núm. 1, pp. 14-17
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis
International Journal of Molecular Sciences, Vol. 24, Núm. 8
-
Clinical and Translational Applications of Serological and Histopathological Biomarkers in Metastatic Breast Cancer: A Comprehensive Review
International Journal of Molecular Sciences, Vol. 24, Núm. 9
-
Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence
Climacteric, Vol. 26, Núm. 4, pp. 388-391
-
Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale
Maturitas, Vol. 172, pp. 46-51
-
Placentas from Women with Late-Onset Preeclampsia Exhibit Increased Expression of the NLRP3 Inflammasome Machinery
Biomolecules, Vol. 13, Núm. 11
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
-
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA
Climacteric, Vol. 26, Núm. 5, pp. 437-444
-
Sequential management of postmenopausal health and osteoporosis: An update
Maturitas, Vol. 177
-
The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: Generalizing the measurement of albuminuria to identify vascular risk and prevent vascular disease
Nefrologia, Vol. 43, Núm. 2, pp. 245-250
-
Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer
Journal of Personalized Medicine, Vol. 13, Núm. 2
-
Vitiligo-like lesions induced by cyclin-dependent kinase 4 and 6 inhibitors
Piel, Vol. 38, Núm. 8, pp. 553-556
-
Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception
Gynecological Endocrinology, Vol. 39, Núm. 1